{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:10:54Z","timestamp":1788120654030,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.dmpk.2021.100411","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:34:20Z","timestamp":1623764060000},"page":"100411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Downregulated expression of organic anion transporting polypeptide (Oatp) 2b1 in the small intestine of rats with acute kidney injury"],"prefix":"10.1016","volume":"40","author":[{"given":"Fuyo","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-3229","authenticated-orcid":false,"given":"Masako","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-7911","authenticated-orcid":false,"given":"Hiroshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2021.100411_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/clpt.2013.86","article-title":"Transporters in drug development and clinical pharmacology","volume":"94","author":"Giacomini","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2021.100411_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100411_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bdd.1823","article-title":"Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption","volume":"34","author":"Shitara","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.dmpk.2021.100411_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cpt.1360","article-title":"Clinical aspects of transporter-mediated drug-drug interactions","volume":"105","author":"Gessner","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2021.100411_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-13-7647-4_5","article-title":"Transporter-mediated drug-drug interactions and their significance","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.dmpk.2021.100411_bib6","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/bph.13785","article-title":"Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease","volume":"174","author":"Murray","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100411_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1600-0676.2001.021004247.x","article-title":"Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis","volume":"21","author":"Oswald","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.dmpk.2021.100411_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep4.1489","article-title":"Interindividual diversity in expression of organic anion uptake transporters in normal and cirrhotic human liver","volume":"4","author":"Taniguchi","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dmpk.2021.100411_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020372","article-title":"Expression of OATP family members in hormone-related cancers: potential markers of progression","volume":"6","author":"Pressler","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.dmpk.2021.100411_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/dmd.109.027367","article-title":"Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients","volume":"37","author":"Wojtal","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2021.100411_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.dmpk.2021.100411_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2174\/1389200219666180103143448","article-title":"Metabolic enzyme system and transport pathways in chronic kidney diseases","volume":"19","author":"Liu","year":"2018","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.dmpk.2021.100411_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/17425255.2021.1899159","article-title":"Renal and non-renal response of ABC and SLC transporters in chronic kidney disease","volume":"17","author":"Torres","year":"2021","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.dmpk.2021.100411_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.106.112631","article-title":"Down-regulation of intestinal drug transporters in chronic renal failure in rats","volume":"320","author":"Naud","year":"2007","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.dmpk.2021.100411_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.kint.2017.04.032","article-title":"Impairment of the carnitine\/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease","volume":"92","author":"Shinozaki","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.dmpk.2021.100411_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/0886022X.2019.1628780","article-title":"Acute toxic kidney injury","volume":"41","author":"Petejova","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.dmpk.2021.100411_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40266-017-0484-4","article-title":"Drug-induced kidney injury in the elderly","volume":"34","author":"Khan","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.dmpk.2021.100411_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dmpk.2021.100411_bib19","doi-asserted-by":"crossref","first-page":"F1513","DOI":"10.1152\/ajprenal.00419.2018","article-title":"Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states","volume":"315","author":"Polichnowski","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.dmpk.2021.100411_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/0886022X.2019.1602054","article-title":"The prominent impairment of liver\/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison","volume":"41","author":"Sukkummee","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.dmpk.2021.100411_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115570","article-title":"Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain \"gatekeeper\" function","volume":"423","author":"Takeda","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100411_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.103.051300","article-title":"Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane","volume":"306","author":"Kobayashi","year":"2003","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.dmpk.2021.100411_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.119.089656","article-title":"Quantitative proteomics of clinically relevant drug-metabolizing enzymes and drug transporters and their intercorrelations in the human small intestine","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2021.100411_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2133\/dmpk.DMPK-12-RV-099","article-title":"Impact of genetic variation in OATP transporters to drug disposition and responses","volume":"28","author":"Gone","year":"2013","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2021.100411_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0928-0987(00)00113-5","article-title":"Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system","volume":"11","author":"Nakayama","year":"2000","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2021.100411_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1023\/A:1016217505990","article-title":"Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine","volume":"12","author":"Saitoh","year":"1995","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2021.100411_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jphp.13019","article-title":"Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier","volume":"71","author":"Dunkoksung","year":"2019","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100411_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","article-title":"Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment","volume":"250","author":"Aleksunes","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.dmpk.2021.100411_bib29","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s11095-008-9668-2","article-title":"Regulation of renal ion transporters in cisplatin-induced acute kidney injury and uremia in rats","volume":"25","author":"Morisaki","year":"2008","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2021.100411_bib30","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Qun","year":"2018","journal-title":"Dalton Trans"},{"key":"10.1016\/j.dmpk.2021.100411_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2018.03.009","article-title":"Cisplatin-induced gastrointestinal toxicity: an update on possible mechanisms and on available gastroprotective strategies","volume":"827","author":"Shahid","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100411_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835918821021","article-title":"D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation","volume":"11","author":"Wu","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.dmpk.2021.100411_bib33","first-page":"2076","article-title":"The protective effect of infliximab on cisplatin-induced intestinal mucosa toxicity","volume":"18","author":"Aydin","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.dmpk.2021.100411_bib34","first-page":"276186","article-title":"Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats","author":"Yamamoto","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.dmpk.2021.100411_bib35","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.REV120.009132","article-title":"Post-translational regulation of the major drug transporters in the families of organic anion-transporters and organic anion transporting polypeptides","volume":"295","author":"Lee","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dmpk.2021.100411_bib36","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-07-4793","article-title":"Interaction of cisplatin with the human organic cation transporter 2","volume":"14","author":"Filipski","year":"2008","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.dmpk.2021.100411_bib37","first-page":"15","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.dmpk.2021.100411_bib38","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.xphs.2017.04.004","article-title":"Intestinal drug interactions mediated by OATPs: a systematic review of preclinical and clinical findings","volume":"106","author":"Yu","year":"2017","journal-title":"J\u00a0Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2021.100411_bib39","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-010-0216-5","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide","volume":"27","author":"Shirasaka","year":"2010","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2021.100411_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.120.000267","article-title":"Transport properties of statins by organic anion transporting polypeptide 1A2 and regulation by transforming growth factor- \u03b2 signaling in human endothelial cells","volume":"376","author":"Ronaldson","year":"2021","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.dmpk.2021.100411_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semnephrol.2009.07.008","article-title":"Acute kidney injury in the elderly: problems and prospects","volume":"29","author":"Himmelfarb","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.dmpk.2021.100411_bib42","first-page":"457","article-title":"Polypharmacy and medication management in older adults","volume":"52","author":"Kim","year":"2017","journal-title":"Nurs Clin"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134743672100032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134743672100032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:55:49Z","timestamp":1761162949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134743672100032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S134743672100032X"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2021.100411","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulated expression of organic anion transporting polypeptide (Oatp) 2b1 in the small intestine of rats with acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2021.100411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100411"}}